NSSA hosts interactive session with Emirati astronauts ahead of Bahrain's "Al Munther" satellite launch
As Bahrain prepares to launch its 'Al Munther' satellite in March, the National Space Science Agency (NSSA), in collaboration with the Mohammed bin Rashid Space Centre (MBRSC) in the United Arab Emirates, hosted an interactive virtual session featuring Emirati astronauts Mohammed Al Mulla and Nora Al Matrooshi.
The session engaged more than 1,000 students from ten educational institutions, including universities and public and private schools across Bahrain.
Discussions covered key topics such as the role of space investment in economic development, the space sector's contributions to sustainable development goals, and advancements in satellite technology, particularly the growing shift towards small and nano satellites. The session also highlighted the upcoming launch of Bahrain's Al Munther satellite, which incorporates artificial intelligence for data and image analysis, as well as Bahrain-UAE space cooperation and its impact on innovation and sustainability in the region.
The astronauts emphasised the importance of scientific and technical disciplines for youth aspiring to enter the space sector, underscoring the role of ambition and knowledge in advancing this promising field.
Dr. Mohamed Ibrahim Al Aseeri, CEO of the NSSA, stated that the session aligns with the directives of Lieutenant General His Highness Shaikh Nasser bin Hamad Al Khalifa, National Security Advisor, Royal Guard Commander, and Secretary General of the Supreme Defence Council. He noted that the event coincides with the NSSA's preparations for the launch of the Al Munther satellite.
The initiative is part of NSSA's efforts to promote space science awareness among young people and create opportunities for students and enthusiasts to explore new frontiers in the growing space sector.
BNA(R)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Trade Arabia
2 days ago
- Trade Arabia
M42, partners launch liquid biopsy testing in UAE
M42, a global health leader powered by technology, continues to pioneer artificial intelligence (AI) and medical and clinical solutions as part of its mission to revolutionise health in the UAE and globally. In a major advancement for precision oncology, M42 announced a strategic collaboration with AstraZeneca and SOPHiA Genetics to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of cancers. As part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS, powered with SOPHiA DDM technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood draw. This approach does not replace but rather complements routine cancer screenings and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer profile. Over the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the UAE. The new testing programme will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the region. Validation studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 2025. Over time, the collaboration will serve as a foundation for broader expansion across the Middle East, excluding Saudi Arabia, delivering world-class precision oncology solutions to a wider population. Albarah El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said: "At M42, we are committed to transforming care through innovation and collaboration. By partnering with AstraZeneca and SOPHiA GENETICS, we are bringing world-class liquid biopsy technologies to the UAE, empowering clinicians to deliver more precise and less invasive cancer care. This collaboration reflects our vision of democratizing health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalized care." Sameh El Fangary, Cluster President GCC, AstraZeneca, shared:"At AstraZeneca, we are leading the way in the application of precision medicine. Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimizing patient pathways from detection to therapy.'
Trade Arabia
2 days ago
- Trade Arabia
ALTÉRRA backs Absolute Energy to develop renewable capacity in Italy
ALTÉRRA, the UAE's $30 billion climate investment vehicle, today announced a €50 million commitment via ALTÉRRA Acceleration Fund to Absolute Energy, an innovative Italian renewable energy platform. The co-investment, made alongside global infrastructure investment manager, I Squared Capital, will help accelerate the development of an initial active pipeline of 1.4GW projects across Italy. Absolute Energy focuses on the rapid development of multiple commercially viable small to medium-scale solar projects across Italy, leveraging the country's supportive regulatory environment - including accelerated permitting processes and guaranteed grid access. Through this initial buildout of 1.4GW of solar and battery storage capacity, along with a broader development pipeline of over 6GW, Absolute Energy is well positioned to become a next-generation Independent Power Producer (IPP) playing a key role in advancing Italy's decarbonization and energy independence goals. ALTÉRRA estimates that this 1.4GW pipeline could eliminate up to 380,000 metric tons of carbon dioxide equivalent (CO₂e) emissions annually. Italy has set a national target of adding 46GW of new solar capacity by 2030 to advance its net zero ambitions, address rising power demand, strengthen energy security, and reduce dependence on energy imports. Benefiting from favourable conditions such as high solar irradiation levels coupled with supportive policies, Italy represents a compelling market opportunity for advancing solar infrastructure at a pivotal moment in Europe's energy transition. Majid Al Suwaidi, CEO of ALTÉRRA, commented: 'We are excited to support Absolute Energy as it enters its next phase of growth. With a strong pipeline and deep sector expertise, the company will help drive Italy's clean energy future. ALTERRA invests to accelerate the climate transition through innovative approaches and partnerships. In working with a global leader like I Squared Capital with their strong track record in platform building and investing in renewables, this investment further demonstrates how ALTERRA works with partners to invest at scale to accelerate impact across key markets.' Sadek Wahba, Chairman and Managing Partner of I Squared Capital, said: 'We are proud to welcome ALTÉRRA as a strategic partner in Absolute Energy. Their investment underscores the strength of the platform and the scale of the opportunity in accelerating Italy's energy transition. ALTÉRRA brings deep climate focus and ambition, and we share their commitment to deploying capital with urgency and impact. This partnership is a powerful endorsement of Absolute Energy's innovative model and I Squared's long-standing approach to building transformational infrastructure businesses in critical sectors around the world.' -
Trade Arabia
29-05-2025
- Trade Arabia
Emsteel achieves industrial-scale decarbonised cement success
Emsteel, one of the largest publicly traded steel and building materials manufacturers in the region, has announced a major milestone in its decarbonisation journey with the signing of a strategic partnership with Finnish company Magsort to produce decarbonised cement. The agreement follows the success the group has had in implementing an industrial-scale pilot for decarbonised cement production at its Al Ain facility through utilising 10,000 tonnes of materials that reduce carbon, which have been developed by incorporating steel-slag. Emsteel Group's pilot provides a unique use-case for complementary operations between its two main business lines: steel and cement. This is achieved by incorporating steel slag at scale as raw material for clinker and cement production, reinforcing the group's commitment towards driving sustainability in the sector. Due to its diverse product range, Emsteel is uniquely positioned to pioneer a viable and practical circular economy case study. This simultaneously underscores Emsteel's strategic capability to expedite decarbonisation efforts across diverse sectors and strengthens its standing as a regional sustainability leader setting new benchmarks for industrial innovation in developing low-carbon cement, the company said. To address the growing local market demand for low-carbon cement, an integrated line will be built at the company's Al Ain plant. This line will process steel residue and refine materials sourced from EMSTEEL's steel plant in Abu Dhabi. This significant initiative is a crucial step expected to directly contribute to reducing Scope 1 carbon dioxide emissions. This initiative is a core component of Emsteel's decarbonisation strategy. The company aims to achieve a 40% reduction in absolute greenhouse gas (GHG) emissions in its Steel Business Unit and by 30% reduction in its Cement Business Unit by 2030, using 2019 as the baseline year. Emsteel remains firmly committed to reaching net-zero emissions by 2050. Eng Saeed Ghumran Al Remeithi, Group CEO of Emsteel, said: 'This is a proud moment for Emsteel and a strong signal of what is possible when innovation meets ambition. By transforming steel slag into a valuable input for cement, we are not only cutting emissions but also proving the commercial value of industrial circularity. Our integrated model is unlocking real results, and this milestone is a testament to our commitment to accelerate our decarbonisation journey and help deliver the UAE's Net Zero vision.' Hugo Losada, CEO of Emirates Cement, part of Emsteel Group, said: 'This milestone represents an important step in our decarbonisation journey. Proving the technical and commercial viability of this decarbonisation effort is a promising sign that we will be able to achieve our objective of hitting the 2030 decarbonisation targets by 2026. We look forward to continuing this very fruitful co-operation with Magsort over the years to come.' Kalevi Kostiainen, CEO of Magsort, said: 'We are extremely happy in achieving this key milestone in Abu Dhabi. The co-operation with Emirates Cement has been incredibly productive and this facility serves as a large-scale example for the industry on how to achieve significant CO₂ reduction with today's technology and existing materials. It's a clear win-win for the cement and steel industries. We would like to thank Emirates Cement for leading the way and taking action.' -
